MedTech Industry Dynamics
MedTech Industry Dynamics
QIAGEN has launched QIAsymphony Connect, an IVD-compliant automated platform for clinical nucleic acid extraction that builds on more than 3,300 cumulative placements of the established QIAsymphony platform while using the same reagent kits and consumables.
更多内容QIAGEN has appointed Jonathan M. Pratt as Chief Executive Officer, who brings more than 25 years of leadership experience across life sciences and laboratory technologies, including serving as CEO of Filtration Group and president of Beckman Coulter Life Sciences.
更多内容a flexible platform for automated sample processing that will now be available to molecular diagnostic laboratories in the U.S. and Canada, the European Union and other markets worldwide
更多内容QIAGEN has placed more than 1,100 QIAstat-Dx instruments worldwide in hospitals, clinics and laboratories, including over 200 in the U.S.
更多内容As the first syndromic testing solution in the European Union for use in the coronavirus epidemic, the QIAstat-Dx test kit can differentiate the SARS-CoV-2 coronavirus from 21 other serious respiratory infections in patients who may have similar symptoms in a single testing run of about one hour.
更多内容The transaction values QIAGEN at approximately $11.5 billion at current exchange rates, which includes the assumption of approximately $1.4 billion of net debt.
更多内容
